Literature DB >> 1873374

Sleep deprivation therapy.

H Kuhs1, R Tölle.   

Abstract

This review reports, with as much detail as possible, on the literature relating to therapeutic sleep deprivation (or induced-wakefulness therapy) since it was first described in 1971. The antidepressive effect of sleep deprivation has been substantiated by numerous studies. A series of clinical predictors of response to sleep deprivation are also described. Partial sleep deprivation late in the night is equivalent to total sleep deprivation in terms of therapeutic value and--because of its simpler application--can be regarded today as the sleep deprivation method of choice. The status of sleep deprivation in the overall treatment schedule for depressive disorders is discussed in detail. Numerous findings, some of them contradictory, have been published on the effect of sleep deprivation on biological variables. To date, no unequivocal explanation has been found for the mechanism of action of sleep deprivation.

Entities:  

Mesh:

Year:  1991        PMID: 1873374     DOI: 10.1016/0006-3223(91)90255-k

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Diurnal variation in regional brain glucose metabolism in depression.

Authors:  Anne Germain; Eric A Nofzinger; Carolyn C Meltzer; Annette Wood; David J Kupfer; Robert Y Moore; Daniel J Buysse
Journal:  Biol Psychiatry       Date:  2007-01-09       Impact factor: 13.382

2.  Effect of sleep deprivation on the growth hormone response to the alpha-3 adrenergic receptor agonist, clonidine, in normal subjects.

Authors:  S Lal; J X Thavundayil; B Krishnan; N P Nair; G Schwartz; M E Kiely; H Guyda
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Sleep quality in healthy and mood-disordered persons predicts daily life emotional reactivity.

Authors:  Kimberly O'Leary; Brent J Small; Vanessa Panaite; Lauren M Bylsma; Jonathan Rottenberg
Journal:  Cogn Emot       Date:  2016-01-12

Review 4.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

5.  Sleep deprivation hastens the antidepressant action of fluoxetine.

Authors:  F Benedetti; B Barbini; A Lucca; E Campori; C Colombo; E Smeraldi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

6.  Antidepressant effects of selective slow wave sleep deprivation in major depression: a high-density EEG investigation.

Authors:  Eric C Landsness; Michael R Goldstein; Michael J Peterson; Giulio Tononi; Ruth M Benca
Journal:  J Psychiatr Res       Date:  2011-03-11       Impact factor: 4.791

7.  Intensive sleep deprivation and cognitive behavioral therapy for pharmacotherapy refractory insomnia in a hospitalized patient.

Authors:  Joshua Breitstein; Brandon Penix; Bernard J Roth; Tristin Baxter; Vincent Mysliwiec
Journal:  J Clin Sleep Med       Date:  2014-06-15       Impact factor: 4.062

8.  Late, but not early, wake therapy reduces morning plasma melatonin: relationship to mood in Premenstrual Dysphoric Disorder.

Authors:  Barbara L Parry; Charles J Meliska; L Fernando Martínez; Ana M López; Diane L Sorenson; Richard L Hauger; Jeffrey A Elliott
Journal:  Psychiatry Res       Date:  2008-09-11       Impact factor: 3.222

9.  Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation.

Authors:  Zita Kátai; Csaba Adori; Tamás Kitka; Szilvia Vas; Lajos Kalmár; Diána Kostyalik; László Tóthfalusi; Miklós Palkovits; György Bagdy
Journal:  Psychopharmacology (Berl)       Date:  2013-03-21       Impact factor: 4.530

10.  The day-to-day acute effect of wake therapy in patients with major depression using the HAM-D6 as primary outcome measure: results from a randomised controlled trial.

Authors:  Klaus Martiny; Else Refsgaard; Vibeke Lund; Marianne Lunde; Lene Sørensen; Britta Thougaard; Lone Lindberg; Per Bech
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.